Clene Statistics
Total Valuation
Clene has a market cap or net worth of $44.50 million. The enterprise value is $41.60 million.
| Market Cap | 44.50M |
| Enterprise Value | 41.60M |
Important Dates
The next estimated earnings date is Friday, May 10, 2024, after market close.
| Earnings Date | May 10, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Clene has 128.43 million shares outstanding. The number of shares has increased by 60.94% in one year.
| Shares Outstanding | 128.43M |
| Shares Change (YoY) | +60.94% |
| Shares Change (QoQ) | -18.28% |
| Owned by Insiders (%) | 40.11% |
| Owned by Institutions (%) | 19.28% |
| Float | 66.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 68.04 |
| Forward PS | 87.61 |
| PB Ratio | 3.32 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 63.61 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.53, with a Debt / Equity ratio of 2.40.
| Current Ratio | 1.53 |
| Quick Ratio | 1.39 |
| Debt / Equity | 2.40 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.86 |
Financial Efficiency
Return on equity (ROE) is -362.00% and return on invested capital (ROIC) is -89.00%.
| Return on Equity (ROE) | -362.00% |
| Return on Assets (ROA) | -89.80% |
| Return on Capital (ROIC) | -89.00% |
| Revenue Per Employee | $7,976 |
| Profits Per Employee | -$603,707 |
| Employee Count | 82 |
| Asset Turnover | 0.01 |
| Inventory Turnover | 3.03 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.52% in the last 52 weeks. The beta is 0.49, so Clene's price volatility has been lower than the market average.
| Beta (1Y) | 0.49 |
| 52-Week Price Change | -63.52% |
| 50-Day Moving Average | 0.40 |
| 200-Day Moving Average | 0.50 |
| Relative Strength Index (RSI) | 42.19 |
| Average Volume (30 Days) | 927,829 |
Short Selling Information
The latest short interest is 148,451, so 0.12% of the outstanding shares have been sold short.
| Short Interest | 148,451 |
| Short Previous Month | 162,889 |
| Short % of Shares Out | 0.12% |
| Short % of Float | 0.22% |
| Short Ratio (days to cover) | 0.35 |
Income Statement
In the last 12 months, Clene had revenue of $654,000 and -$49.50 million in losses. Loss per share was -$0.47.
| Revenue | 654,000 |
| Gross Profit | 533,000 |
| Operating Income | -40.54M |
| Pretax Income | -49.50M |
| Net Income | -49.50M |
| EBITDA | -42.81M |
| EBIT | -44.95M |
| Loss Per Share | -$0.47 |
Balance Sheet
The company has $35.06 million in cash and $32.16 million in debt, giving a net cash position of $2.90 million or $0.02 per share.
| Cash & Cash Equivalents | 35.06M |
| Total Debt | 32.16M |
| Net Cash | 2.90M |
| Net Cash Per Share | $0.02 |
| Equity / Book Value | 13.39M |
| Book Value Per Share | 0.10 |
| Working Capital | 13.52M |
Cash Flow
In the last 12 months, operating cash flow was -$30.17 million and capital expenditures -$330,000, giving a free cash flow of -$30.50 million.
| Operating Cash Flow | -30.17M |
| Capital Expenditures | -330,000 |
| Free Cash Flow | -30.50M |
| FCF Per Share | -$0.29 |
Margins
Gross margin is 81.50%, with operating and profit margins of -6,198.78% and -7,569.42%.
| Gross Margin | 81.50% |
| Operating Margin | -6,198.78% |
| Pretax Margin | -7,569.42% |
| Profit Margin | -7,569.42% |
| EBITDA Margin | -6,545.41% |
| EBIT Margin | -6,872.48% |
| FCF Margin | -4,663.76% |
Dividends & Yields
Clene does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -60.94% |
| Shareholder Yield | -60.94% |
| Earnings Yield | -111.24% |
| FCF Yield | -68.54% |
Analyst Forecast
The average price target for Clene is $7.20, which is 1,977.92% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.20 |
| Price Target Difference | 1,977.92% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 248.53% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | Dec 31, 2020 |
| Split Type | n/a |
| Split Ratio | 1:1 |
Scores
Clene has an Altman Z-Score of -8.32 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.32 |
| Piotroski F-Score | 3 |